Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Pharm Res. 2011 Jan 22;28(5):1049–1064. doi: 10.1007/s11095-010-0356-7

Table I.

Time to Attain 95% of the Steady-State Concentration After Transscleral Drug Administration with a Constant Concentration Source

Condition of the vitreous Time (hours)
Sloshing vitreous μ = 0.01 18.1
μ = 0.1 20.8
μ = 1.0 27.7
Static vitreous 27.9